Transfusion-related acute lung injury: A clinical review

The Lancet

Volumn 382, Issue 9896, 2013, Pages 984-994

  Vlaar, Alexander P J ^a   Juffermans, Nicole P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY MEDIATED TRANSFUSION RELATED ACUTE LUNG INJURY; ARTIFICIAL VENTILATION; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; LUNG EDEMA; MEDICAL RESEARCH; MORTALITY; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMA VOLUME; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED STATES;

EID: 84884141092     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)62197-7     Document Type: Review

References (100)

1. Popovsky MA, Abel MD, Moore SB Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983; 128: 185-89.
2. Goldman M, Webert KE, Arnold D.M., Freedman J., Hannon J, Blajchman MA Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005; 19: 2-31.
3. Kleinman S, Caulfield T, Chan P., et al Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 1774-89.
4. Vlaar AP, Schultz MJ, Juffermans NP Transfusion-related acute lung injury: a change of perspective. Neth J Med 2009; 67: 320-26.
5. Holness L, Knippen MA, Simmons L, Lachenbruch PA Fatalities caused by TRALI. Transfus Med Rev 2004; 18: 184-88.
6. Stainsby D, Jones H, Asher D., et al Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006; 20: 273-82.
7. Kopko PM, Marshall CS, MacKenzie M.R., Holland PV, Popovsky MA Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287: 1968-71.
8. Toy P, Gajic O, Bacchetti P., et al Transfusion related acute lung injury: incidence and risk factors. Blood 2012; 119: 1757-67.
9. Vlaar AP, Hofstra JJ, Determann R.M., et al Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested case-control study. Crit Care Med 2012; 40: 2813-20.
10. Kleinman S. A perspective on transfusion-related acute lung injury two years after the Canadian Consensus Conference. Transfusion 2006; 46: 1465-68.
11. Toy P, Popovsky MA, Abraham E, et al Transfusion-related acute lung injury: definition and review. Crit Care Med 2005; 33: 721-26.
12. Bernard GR, Artigas A, Brigham K.L., et al The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
13. Eder AF, Herron R, Strupp A., et al Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007; 47: 599-607.
14. Wiersum-Osselton J.C., Porcelijn L, van Stein D, Vlaar AP, Beckers E.A., Schipperus MR. Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005. Ned Tijdschr Geneeskd 2008; 152: 1784-88 (in Dutch).
15. Vlaar AP, Hofstra JJ, Determann R.M., et al The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117: 4218-25.
16. Silliman CC, Voelkel NF, Allard J.D., et al Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998; 101: 1458-67.
17. Silliman CC, Bjornsen AJ, Wyman T.H., et al Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003; 43: 633-40.
18. Vlaar AP, Binnekade JM, Prins D, et al Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med 2010; 38: 771-78.
19. Gajic O, Rana R, Winters J.L., et al Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007; 176: 886-91.
20. Marik PE, Corwin HL Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008; 36: 3080-84.
21. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006; 34: S124-31.
22. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62.
23. Guichard C, Pedruzzi E, Dewas C., et al Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem 2005; 280: 37021-32.
24. Grundy JE, Lawson KM, MacCormac L.P., Fletcher JM, Yong KL Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 1998; 177: 1465-74.
25. Carlos TM, Harlan JM Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101.
26. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009; 119: 3450-61.
27. Thomas GM, Carbo C, Curtis B.R., et al Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 2012; 119: 6335-43.
28. Caudrillier A, Kessenbrock K, Gilliss B.M., et al Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122: 2661-71.
29. Leger R, Palm S, Wulf H., Vosberg A, Neppert J. Transfusion-related lung injury with leukopenic reaction caused by fresh frozen plasma containing anti-NB1. Anesthesiology 1999; 91: 1529-32.
30. Yomtovian R, Kline W, Press C., et al Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet 1984; 1: 244-46.
31. Zeerleder S, Caliezi C, van Mierto G, et al Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis. Clin Diagn Lab Immunol 2003; 10: 529-35.
32. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA Neutrophils and their Fcgamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006; 6: 1615-23.
33. Curtis BR, McFarland JG Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies. Crit Care Med 2006; 34: S118-23.
34. Popovsky MA, Moore SB Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-77.
35. Sachs UJ, Wasel W, Bayat B., et al Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 2011; 117: 669-77.
36. Vlaar AP, Kuipers M T, Hofstra JJ, et al Mechanical ventilation and the titer of antibodies as risk factors for the development of transfusion-related lung injury. Crit Care Res Pract 2012; 2012: 720950.
37. Kopko PM, Popovsky MA, MacKenzie M.R., Paglieroni TG, Muto KN, Holland PV HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001; 41: 1244-48.
38. Nicolle AL, Chapman CE, Carter V, Wallis JP Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med 2004; 14: 225-30.
39. Toy P, Hollis-Perry KM, Jun J., Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004; 44: 1683-88.
40. Van Buren N.L., Stroncek DF, Clay M.E., McCullough J., Dalmasso AP Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990; 30: 42-45.
41. Mangalmurti NS, Xiong Z, Hulver M., et al Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood 2009; 113: 1158-66.
42. Zhu H, Zennadi R, Xu B.X., et al Impaired adenosine-5'-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion. Crit Care Med 2011; 39: 2478-86.
43. Kelher MR, Masuno T, Moore E.E., et al Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009; 113: 2079-87.
44. Khan SY, Kelher MR, Heal J.M., et al Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108: 2455-62.
45. Ellison MA, Ambruso DR, Silliman CC Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. Curr Pharm Des 2012; 18: 3255-59.
46. Maslanka K, Smolenska-Sym G, Michur H., Wrobel A, Lachert E, Brojer E. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp 2012; 60: 55-60.
47. Vlaar AP, Kulik W, Nieuwland R., et al Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011; 51: 2358-66.
48. Vlaar AP, Hofstra JJ, Levi M, et al Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit," in vivo syngeneic transfusion model. Anesthesiology 2010; 113: 92-103.
49. Vlaar AP, Hofstra JJ, Kulik W, et al Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010; 116: 1360-68.
50. Engelfriet CP, Reesink HW, Brand A, et al Transfusion-related acute lung injury (TRALI). Vox Sang 2001; 81: 269-83.
51. Bux J, Sachs UJ The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136: 788-99.
52. Henderson RA, Pinder L. Acute transfusion reactions. N Z Med J 1990; 103: 509-11.
53. Clarke G. Severe respiratory reactions to random donor platelets: an incidence and nested case-control study. Blood 1994; 84: 465a.
54. Wallis JP, Lubenko A, Wells A.W., Chapman CE Single hospital experience of TRALI. Transfusion 2003; 43: 1053-59.
55. Rana R, Fernandez-Perez ER, Khan S.A., et al Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46: 1478-83.
56. Benson AB, Austin GL, Berg M, et al Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Med 2010; 36: 1710-17.
57. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest 1995; 108: 767-71.
58. Corwin HL, Gettinger A, Pearl R.G., et al The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
59. Fadeyi EA, De Los Angeles MM, Wayne AS, Klein HG, Leitman SF, Stroncek DF. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007; 47: 545-50.
60. Vlaar AP, Porcelijn L, van Rooijen-Schreurs IH, Lardy NM, Kersten MJ, Juffermans NP The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports. Med Sci Monit 2010; 16: CS129-134.
61. Rollins MD, Molofsky AB, Nambiar A, Pandey S., Weiskopf RB, Toy P. Two septic transfusion reactions presenting as transfusion-related acute lung injury from a split plateletpheresis unit. Crit Care Med 2012; 40: 2488-91.
62. Gajic O, Gropper MA, Hubmayr RD Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 2006; 34: S109-113.
63. Li G, Daniels CE, Kojicic M, et al The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009; 49: 13-20.
64. Zimmerman GA, Morris AH, Cengiz M. Cardiovascular alterations in the adult respiratory distress syndrome. Am J Med 1982; 73: 25-34.
65. Wiedemann HP, Wheeler AP, Bernard G.R., et al Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-75.
66. Davis A, Mandal R, Johnson M., Makar R, Stowell C, Dzik S. A touch of TRALI. Transfusion 2008; 48: 541-45.
67. Moore SB. Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med 2006; 34: S114-117.
68. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-08.
69. Popovsky MA. Transfusion and lung injury. Transfus Clin Biol 2001; 8: 272-77.
70. Khan H, Belsher J, Yilmaz M., et al Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007; 131: 1308-14.
71. Marik PE, Corwin HL Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36: 2667-74
72. Vlaar AP, Wolthuis EK, Hofstra J.J., et al Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies. Intensive Care Med 2010; 36: 879-87.
73. Partrick DA, Moore EE, Fullerton D.A., Barnett Jr. CC, Meldrum DR, Silliman CC Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res 1999; 86: 42-49.
74. Hébert P.C., Wells G, Blajchman M.A., et al A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17.
75. Napolitano LM, Corwin HL Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin 2004; 20: 255-68.
76. Vincent JL, Piagnerelli M. Transfusion in the intensive care unit. Crit Care Med 2006; 34: S96-101.
77. Jones HP, Jones J, Napier J.A., al-Ismail S. Clinical use of FFP: results of a retrospective process and outcome audit. Transfus Med 1998; 8: 37-41.
78. Luk C, Eckert KM, Barr R.M., Chin-Yee IH. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines. CMAJ 2002; 166: 1539-40.
79. Moylan S, Szabo F, Scott H., Kwok G. Use of fresh-frozen plasma at Royal Darwin Hospital: a retrospective audit. Intern Med J 2008; 38: 686-91.
80. Wallis JP, Dzik S. Is fresh frozen plasma overtransfused in the United States? Transfusion 2004; 44: 1674-75.
81. Yilmaz M, Keegan MT, Iscimen R, et al Toward the prevention of acute lung injury: protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007; 35: 1660-66.
82. Middelburg RA, Borkent B, Jansen M., et al Storage time of blood products and transfusion-related acute lung injury. Transfusion 2012; 52: 658-67.
83. Fergusson DA, Hebert P, Hogan D.L., et al Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012; 308: 1443-51.
84. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: when is it not safe? Crit Care Med 2003; 31: S687-97.
85. Vlaar AP, Wortel K, Binnekade J.M., et al The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines. Transfusion 2009; 50: 443-51.
86. Win N, Chapman CE, Bowles K.M., et al How much residual plasma may cause TRALI? Transfus Med 2008; 18: 276-80.
87. Kakaiya RM, Triulzi DJ, Wright D.J., et al Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010; 50: 1328-34.
88. Middelburg RA, Porcelijn L, Lardy N., Briet E, Vrielink H. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang 2011; 100: 327-35.
89. Triulzi DJ, Kleinman S, Kakaiya R.M., et al The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-35.
90. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 2001; 41: 317-22.
91. Wright SE, Snowden CP, Athey S.C., et al Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasma. Crit Care Med 2008; 36: 1796-802.
92. Serious Hazards of Transfusion (SHOT). Annual report 2005. Nov 30, 2006. http://www.shotuk.org/wp-content/uploads/2010/03/SHOT-report-2005.pdf (accessed March 12, 2013).
93. Eder AF, Herron RM Jr, Strupp A, et al Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2010; 50: 1732-42.
94. Wiersum-Osselton J.C., Middelburg RA, Beckers E.A., et al Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: before-and-after comparative cohort study. Transfusion 2011; 51: 1278-83.
95. Nakazawa H, Ohnishi H, Okazaki H., et al Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study. Transfusion 2009; 49: 2434-41.
96. Lin Y, Saw CL, Hannach B, Goldman M. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services. Transfusion 2012; 52: 567-74.
97. Vlaar AP, Binnekade JM, Schultz M.J., Juffermans NP, Koopman MM Preventing TRALI: ladies first, what follows? Crit Care Med 2008; 36: 3283-84.
98. Sachs UJ, Kauschat D, Bein G. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 2005; 45: 1628-31.
99. Flesland O. A comparison of complication rates based on published haemovigilance data. Intensive Care Med 2007; 33 (SUPPL. 1): S17-21.
100. Neisser-Svae A., Bailey A, Gregori L., et al Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG. Vox Sang 2009; 97: 226-33.